How does oxytocin affect brain functioning in people at high risk of developing psychosis?

Key information made simple

This study is looking at whether This is a randomised, double-blind, 40 IU intranasal oxytocin versus placebo single-dose challenge with a crossover design (1-week washout) can help people with Schizophrenia, schizotypal and delusional disorders or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to This is a randomised, double-blind, 40 IU intranasal oxytocin versus placebo single-dose challenge with a crossover design (1-week washout), but direct benefit is not guaranteed.

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.